Merck brings contract sales reps onboard

Share this article:
Merck announced a strategic partnership with inVentiv Health, whereby Merck will utilize inVentiv's contract sales staff to supplement Merck's in-house sales force.

The move comes in the wake of Merck's elimination of 15% of its U.S. sales force (1,200 jobs) four months ago.

According to a Dow Jones Newswire report, Whitehouse Station, NJ-based Merck, rather than recruit, hire or keep full-time representatives on the books, has decided to create a more flexible approach so as the market demands change, Merck can expand and contract the number of reps that is has at its disposal.

Merck didn't reveal how many inVentiv reps will be recruited or which drugs they'll be promoting. However, according to the Dow Jones report, the partnership does not include vaccines or drugs marketed to oncologists, ophthalmologists, or dermatologists.

InVentiv's Marcia Frederick said the company is seeing an upswing in its contract sales force business.

Separately, InVentiv announced that it has ended a contract with Boehringer Ingelheim, while initiating nine new sales team agreements including Merck.

 


Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.